Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COX6CP14 (cytochrome c oxidase subunit 6C pseudogene 14) is classified as a pseudogene—a nonfunctional DNA segment that bears high homology to the functional COX6C gene, which encodes cytochrome c oxidase subunit VIc of the mitochondrial respiratory chain[1][4]. Unlike its functional counterpart COX6C, which is essential in mitochondrial oxidative phosphorylation and apoptosis, COX6CP14 does not produce a protein and is not known to be functionally active[4]. Most pseudogenes, including COX6CP14, are not considered direct therapeutic targets and do not encode a receptor, enzyme, transporter, or related druggable molecule[4][2]. Pseudogenes can in some cases act as regulatory elements or as decoys in RNA networks, and recent research suggests a few pseudogenes may be associated with clinical outcomes when expressed, notably in cancer biology; however, COX6CP14 itself has no specific evidence of such a role[2][4][6]. No interacting drugs, direct molecular function, or established disease associations are known for COX6CP14.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 6C pseudogene 14 (COX6CP14).